Skip to main content
Move the World.

In 2013, the FDA banned 23andMe from telling customers about their genetic health risks. Now, after a five-year battle, 23andMe has finally won FDA approval to tell people if they have three mutations associated with a higher risk of breast cancer. It's a landmark legal achievement that could help usher in a new age of personalized medicine.

The Backstory: Before the FDA ban, 23andMe could tell you what scientific studies had discovered about your genetic risk for over 125 health conditions and 30 different drug reactions. They cautioned that a genetic predisposition wasn’t a diagnosis of an actual disease, and, of course, everyone should talk to their doctor to confirm any positive test and discuss options. Even better, they helped people understand their results by rating the quality of the science: a genetic risk with multiple large studies behind it got four stars, and small preliminary research got one star

Whose DNA Is It, Anyway? The government put a stop to all that in 2013, arguing that people could not be trusted to handle information about their own DNA. Specifically, the FDA said that you might get a false positive, and women who heard they had a higher risk of breast cancer might rush out in a panic to get unnecessary chemotherapy or a mastectomy (as though any doctor would do surgery without double-checking the test, explaining the results, and discussing options). After the ban, 23andMe could only tell you gimmicky stuff, like how much caffeine you might like to drink and whether your big toe was longer than your second toe. It went from a sophisticated healthcare tool to one step above a Facebook quiz about which Game of Thrones character you are (Bran).

The Breakthrough: Almost five years later, the FDA approved the first direct-to-consumer test for genetic cancer risk, finally letting 23andMe tell its customers what it has always known about their health. The company" CEO tweeted her relief:

It joins seven other health risk tests the FDA has now authorized, including reports on some genes associated with Celiac, Parkinson", and Alzheimer".

1,001 Things You Still Can't Know: Unfortunately, what 23andMe is allowed to share is still pretty limited. They can only tell you about three mutations on the BRCA gene that are associated with breast and ovarian cancers. These are almost exclusively found in Ashkenazi Jews, so the test is unlikely to tell most women anything about their risk. Over 1,000 other BRCA mutations have been linked to elevated cancer risk, and 23andMe still can't tell you anything about them — or the 117 other health conditions they used to test for. But it's a start, and perhaps the start of a revolution in healthcare and patients' rights.

Up Next

Uprising
Robots for Autism Teach Human Emotion
Robots for Autism Teach Human Emotion
Uprising
Robots for Autism Teach Human Emotion
Meet the classroom assistant of the future, a robot for autism therapy that’s teaching special needs students about empathy and emotions.

Meet the classroom assistant of the future, a robot for autism therapy that’s teaching special needs students about empathy and emotions.

Future of Medicine
Using Artificial Intelligence to Improve Breast Cancer Screening
Scientists Are Using AI to Improve Breast Cancer Screening
Future of Medicine
Using Artificial Intelligence to Improve Breast Cancer Screening
Computer scientists at MIT created a new algorithm for breast cancer screening to predict whether a patient will develop the disease in the next 5 years.

Computer scientists at MIT created a new algorithm for breast cancer screening to predict whether a patient will develop the disease in the next 5 years.

Dispatches
The First Private Moonshot Is Ready to Launch
The First Private Moonshot Is Ready to Launch
Dispatches
The First Private Moonshot Is Ready to Launch
The Israeli group's moon mission will be ride-sharing on a SpaceX rocket.
By John Horack

The Israeli group's moon mission will be ride-sharing on a SpaceX rocket.

Dispatches
AI Will Make You Smarter
AI Will Make You Smarter
Dispatches
AI Will Make You Smarter
Artificial intelligence will multiply your own intelligence, in ways that will surprise you.
By Terrence Sejnowski

Artificial intelligence will multiply your own intelligence, in ways that will surprise you.

Superhuman
Can Genetically Modified Pigs Be the Key to Treating Rare Diseases?
Can Genetically Modified Pigs Be the Key to Treating Rare Diseases?
Watch Now
Superhuman
Can Genetically Modified Pigs Be the Key to Treating Rare Diseases?
When it comes to rare diseases, doctors often don’t have enough patients to determine the effectiveness of various treatments. Now, scientists are breeding pigs with the same genetic code as people with a disease in order to create a pool of test "patients" unlike any before.
Watch Now

There are thousands of diseases known to modern medicine without any cure or treatment. Many are too rare to get much attention from doctors, governments, or drug companies. But the gene editing tool CRISPR is offering hope for people with rare and hard to study diseases, like the genetic disease known as NF1. There are tens of thousands of Americans with this tumor-causing nerve disease, but because it has over 4,000...

Coded
The People’s NSA
The People’s NSA
Watch Now
Coded
The People’s NSA
Hackers and journalists team up to expose crime and corruption around the world
Watch Now

At an undisclosed location in Sarajevo, a group of hackers are working with journalists to expose organized crime and corruption. But those engaged in illicit activity respond with cyber attacks and other intimidation tactics. Can the group fight off the attacks and help journalists bring the truth to light?

Superhuman
The Promise of Gene Therapy
The Promise of Gene Therapy
Watch Now
Superhuman
The Promise of Gene Therapy
When Karen was told her daughter had an incurable disease, she started a gene therapy company to find a cure.
Watch Now

When doctors told Karen there was no cure for her daughter’s brain disease, she took matters into her own hands. With no scientific background, she created a gene therapy business that can fix the faulty genes in patients like her daughter. Now she’s racing against the clock to extend her daughter’s life and improve the lives of others.